Pfizer to Request FDA Emergency Use Authorization for Covid-19 Vaccine Today

In some good news, we’ve reached a critical milestone in the journey to producing a safe and effective Covid-19 vaccine globally. Pfizer, and partner BioNTech, will attempt to request FDA Emergency-Use approval today. They are on track to become the first companies to seek the special authorization for their promising Covid-19 vaccine. This comes after their announcement earlier this week that their potential coronavirus treatment had a 95% efficacy rate with no severe side effects. They received these results while conducting their phase three trials. This vaccine is ten months in the making. Health and Human Services Secretary Alex Azar attributed their rapid success to the Trump Administration’s Operation Warp Speed plan. Azar added, “hope and help are on the way” as the U.S. continues to fight against a pandemic that has killed over a quarter million of Americans. Pfizer, along with Azar, said they have doses on stand by and ready to distribute as soon as they get the signature. They hope to provide 40 million doses by the end of the year. Moderna vaccine has also been labeled a “game changer” with a 94.5% effectiveness. They are looking to get emergency approval and distribute their drug alongside Pfizer’s very soon.